Oligodendroglioma, Childhood
2 clinical trials · Condition
◉ Watch Oligodendroglioma, Childhood
| Record | Firm | Date |
|---|---|---|
| Pediatric Long-Term Follow-up and Rollover Study (NCT03975829) | Novartis Pharmaceuticals | 2019-11-04 |
| Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors (NCT02684058) | Novartis Pharmaceuticals | 2017-12-28 |
Track Oligodendroglioma, Childhood automatically
Every clearance here is in the API, with alerts when new ones post.